Motivation: With the rapid increase of infection resistance to antibiotics, it is urgent to find
novel infection therapeutics. In recent years, antimicrobial peptides (AMPs) have been …

The emergence of multidrug-resistant pathogens and their rapid adaptation against new
antibiotics is a major challenge for scientists and medical professionals. Different …

Antimicrobial peptides (AMPs) have been identified as a potential new class of anti-
infectives for drug development. There are a lot of computational methods that try to predict …

The emergence of antibiotic-resistant clinical isolates and the decreased rate of
development of new antibiotics are a constant threat to human health. In this context, the …

Antimicrobial peptides (AMPs) represent promising alternatives to fight against bacterial
pathogens. However, cellular toxicity remains one of the main concerns in the early …

Antimicrobial peptides (AMPs) have been identified as a potentially new class of antibiotics
to combat bacterial resistance to conventional drugs. The design of de novo AMPs with high …

Ubiquicidin (UBI)/ribosomal protein S30 (RS30) is an intracellular protein with antimicrobial
activities against various pathogens. UBI (29–41) and UBI (31–38) are two crucial peptides …

Antimicrobial peptides (AMPs) have emerged as promising therapeutic alternatives to fight
against the diverse infections caused by different pathogenic microorganisms. In this …

Scorpion venom peptides are generally classified into two main groups: the disulfide
bridged peptides (DBPs), which usually target membrane-associated ion channels, and the …

Peptidic supramolecules formed via self-and co-assembly are intensively studied and
exploited from materials chemistry to biomedicine. Recently we have demonstrated that …